Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Cyclin-dependent kinase 9 | ||
Ligand | BDBM126500 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_2232506 (CHEMBL5146278) | ||
IC50 | <0.500000±n/a nM | ||
Citation | Xie, Z; Hou, S; Yang, X; Duan, Y; Han, J; Wang, Q; Liao, C Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts. J Med Chem65:6356-6389 (2022) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Cyclin-dependent kinase 9 | |||
Name: | Cyclin-dependent kinase 9 | ||
Synonyms: | C-2K | CDC2L4 | CDK9 | CDK9_HUMAN | Cell division cycle 2-like protein kinase 4 | Cell division protein kinase 9 | Cyclin-Dependent Kinase 9 (CDK9) | Cyclin-dependent kinase 9 (CDK9) | Serine/threonine-protein kinase PITALRE | TAK | Tat-associated kinase complex catalytic subunit | ||
Type: | Enzyme Subunit | ||
Mol. Mass.: | 42789.13 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 372 | ||
Sequence: |
| ||
BDBM126500 | |||
n/a | |||
Name | BDBM126500 | ||
Synonyms: | US11591322, Compound NVP-2 | US8778951, 310 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H37ClN6O2 | ||
Mol. Mass. | 513.075 | ||
SMILES | COC[C@@H](C)N[C@H]1CC[C@@H](CC1)Nc1cc(c(Cl)cn1)-c1cccc(NCC2(CCOCC2)C#N)n1 |r,wU:9.12,wD:6.5,3.3,(7.56,1.68,;6.23,2.45,;4.9,1.68,;3.56,2.45,;3.56,3.99,;2.23,1.68,;.89,2.45,;.89,3.99,;-.44,4.76,;-1.77,3.99,;-1.77,2.45,;-.44,1.68,;-3.11,4.76,;-4.44,3.99,;-4.44,2.45,;-5.77,1.68,;-7.11,2.45,;-8.44,1.68,;-7.11,3.99,;-5.77,4.76,;-5.77,.14,;-7.11,-.63,;-7.11,-2.17,;-5.77,-2.94,;-4.44,-2.17,;-3.11,-2.94,;-1.77,-2.17,;-.44,-2.94,;-.44,-4.48,;.89,-5.25,;2.23,-4.48,;2.23,-2.94,;.89,-2.17,;-.44,-1.4,;-.44,.14,;-4.44,-.63,)| | ||
Structure |